Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement - Notice for transferring of equity shares to Investor Education and Protection Fund (IEPF)19-07-2021
19-07-2021
Strides Pharma Science Ltd - 532531 - Shareholding for the Period Ended June 30, 2021
Strides Pharma Science Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here16-07-2021
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement - Notice for transferring of equity shares to Investor Education and Protection Fund (IEPF) FY 2013-201413-07-2021
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
The Management Committee of the Board of Directors of the Company in their meeting held today have allotted 23,750 equity shares of face value of Rs. 10/- each to the eligible employees who have exercised their stock options under Strides ESOP 2016 Plan. These shares shall rank in pari passu with the existing equity shares of the Company in all respects. Consequent to above, the paid-up share capital of the Company has increased from Rs. 89,69,34,140/- consisting of 8,96,93,414 equity shares to Rs. 89,71,71,640/- consisting of 8,97,17,164 equity shares of Rs. 10/- each.30-06-2021
Strides Pharma Science Ltd - 532531 - Compliances-Reg.24(A)-Annual Secretarial Compliance
In compliance with SEBI Circular No. CIR/ CFD/ CMD1/ 27/ 2019 dated February 8, 2019, please find enclosed copy of Annual Secretarial Compliance Report dated May 26, 2021 for the year ended March 31, 2021 issued by M/s. Gopalakrishnaraj H H & Associates, Practicing Company Secretaries. We request you to kindly take the same on record.29-06-2021
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Strides announces successful completion of EU GMP inspection at Puducherry facility28-06-2021
Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding Issue of duplicate share certificate under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - SATISH CHANDRA SHARMA25-06-2021
Strides Pharma Science Ltd - 532531 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
With reference to above, please find enclosed the disclosure of Related Party Transactions, on consolidated basis, for the year ended March 31, 2021 drawn in accordance with applicable accounting standards. This is for your information and records.25-06-2021
Strides Pharma Science Ltd - 532531 - Appointment Of Chief Human Resource Officer
We wish to inform you that Dr Tanaya Mishra (Tanaya) has joined Strides as the Chief Human Resource Officer (CHRO). Tanaya will be part of the executive management team and spearhead the Human Resources function for Strides globally. Tanaya brings with her strong academic pedigree and over 25 years of global and multi-industry HR leadership experience across Manufacturing, Cement, Retail, Information Technology (IT/ ITES) and Banking & Financial Services (BFSI). At Strides, she will help strategize and drive significant people agenda to enable business aspirations.22-06-2021
Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding request received for issue of duplicate share certificate. Umesh Jain16-06-2021